Vaccine Therapy and Sargramostim Compared With Placebo and Sargramostim Following Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
Clinical trial NCT00089115 · TERMINATED
Trial details
- NCT number
- NCT00089115
- Sponsor
- Favrille
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2004-07-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.